XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 267,625 $ 626,879
Banker’s acceptances 26,697 18,642
Trade accounts receivable, less allowance for credit losses of $69,876 and $13,587,182, respectively 224,638 232,140
Other receivables, less allowance for credit losses of $32,511 and $28,447, respectively 61,275 30,286
Advances to suppliers 23,883 14,960
Inventories 1,649,682 2,266,154
Prepaid expenses 75,627 81,328
Total Current Assets 2,329,427 3,270,389
Property, plant and equipment, net 4,502,479 4,883,401
Right-of-use assets 197,851 38,298
Intangible assets, net 8,775,036 6,695,436
TOTAL ASSETS 15,804,793 14,887,524
Current Liabilities:    
Trade accounts payable 588,739 225,106
Accrued expenses 170,426 247,159
Other payables 2,303,183 2,182,982
Contract liabilities 120,912 162,208
Borrowings from related parties 1,413,340 1,144,985
Lease liabilities 70,326 39,323
Current portion of lines of credit 1,955,880 1,015,525
Total Current Liabilities 6,622,806 5,017,288
Non-current Liabilities:    
Lines of credit, net of current portion 1,391,130
Lease liabilities, net of current portion 128,257
Deferred tax liability 739,733 731,202
Total Liabilities 7,490,796 7,139,620
Commitments and Contingencies (Note 14)
Stockholders’ Equity:    
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued or outstanding
Common stock, $0.001 par value; 500,000,000 shares authorized; 3,261,911 shares and 3,261,911 shares issued and outstanding, respectively 5,022 3,262
Additional paid-in capital 43,076,319 40,631,679
Securities purchase agreement receivable (180,000) (180,000)
Accumulated deficit (45,992,100) (44,026,679)
Accumulated other comprehensive income 11,404,756 11,319,642
Total Stockholders’ Equity 8,313,997 7,747,904
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 15,804,793 $ 14,887,524